Panatuss Pediatric DXP Interactions
There are 570 drugs known to interact with Panatuss Pediatric DXP (dexbrompheniramine/dextromethorphan/phenylephrine), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 94 are major, 473 are moderate, and 3 are minor.
- View all 570 medications that may interact with Panatuss Pediatric DXP
- View Panatuss Pediatric DXP alcohol/food interactions (2)
- View Panatuss Pediatric DXP disease interactions (8)
Most frequently checked interactions
View interaction reports for Panatuss Pediatric DXP (dexbrompheniramine / dextromethorphan / phenylephrine) and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- allopurinol
- amitriptyline
- amlodipine
- ashwaganda
- astragalus
- atenolol
- bendroflumethiazide
- bisoprolol
- black cohosh
- candesartan
- celery
- cephalexin
- chlorthalidone
- clonidine
- colchicine
- CoQ10 (ubiquinone)
- Dermolate (hydrocortisone topical)
- diltiazem
- Estradiol Patch (estradiol)
- fluticasone nasal
- folic acid
- furosemide
- garlic
- Ginkgo Biloba (ginkgo)
- grape seed oil
- hawthorn
- indapamide
- L-Arginine (arginine)
- melatonin
Panatuss Pediatric DXP alcohol/food interactions
There are 2 alcohol/food interactions with Panatuss Pediatric DXP (dexbrompheniramine / dextromethorphan / phenylephrine).
Panatuss Pediatric DXP disease interactions
There are 8 disease interactions with Panatuss Pediatric DXP (dexbrompheniramine / dextromethorphan / phenylephrine) which include:
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- BPH
- diabetes
- glaucoma
Report options
More about Panatuss Pediatric DXP (dexbrompheniramine / dextromethorphan / phenylephrine)
- Panatuss Pediatric DXP consumer information
- Compare alternatives
- Side effects
- Dosage information
- Drug class: upper respiratory combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Promethazine VC with Codeine
Promethazine VC with Codeine is used for cough and nasal congestion
Mucinex D
Mucinex D (guaifenesin and pseudoephedrine) is used to treat nasal and sinus congestion, and to ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Robitussin Nighttime Cough DM
Robitussin Nighttime Cough DM is used for cough, cough and nasal congestion
Vicks Nyquil Cough
Vicks Nyquil Cough is used for cough, cough and nasal congestion
Dextromethorphan/guaifenesin/phenylephrine
Dextromethorphan/guaifenesin/phenylephrine systemic is used for cough and nasal congestion
Brompheniramine/dextromethorphan/pseudoephedrine
Brompheniramine/dextromethorphan/pseudoephedrine systemic is used for cough and nasal congestion
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.